DPHARMA 1.27 (+4.96%) | DUOPHARMA BIOTECH BHD

DPHARMA | DUOPHARMA BIOTECH BHD

1.27 (4.96%)

T-O (am): 1.21 (08:59:00)
Last updated: 16:50

Fundamental

Technical

Total Score

DPHARMA Support & Resistance

ATR Trailing Stop: 1.19

	Support					Last Price	Resistance
Price	1.23	1.24	1.25	1.26	1.27	1.27	1.27	1.28	1.29	1.3	1.31
Volume (M)	69.7	90.7	84.0	52.6	58.6		58.6	42.8	33.0	59.8	37.6

Gann Support: 1.21/1.16 | Resistance: 1.33/1.39

*Highlighted column shows significant volume at the support or resistance area.

DPHARMA Technical Trend

DPHARMA Trading Signals

Based on iSaham Screeners

Moving Average (Short Term)
Moving Average (Mid Term)
Moving Average (Long Term)
Ichimoku Kumo
Bollinger Band
RSI
Stochastic
Heikin-Ashi
MACD
Solid MA Trend
SAT

Sector Trend (Long Term)
Sector Trend (Short Term)
Institutional Holdings
Beat The Insti
Magic Formula
Better Than ASB
52-Week High
BTST
T+
Candlestick
Chart Pattern

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

DPHARMA Pivot Point

	S2	S1	P	R1	R2
Daily	1.18	1.23	1.25	1.3	1.32
Weekly	1.16	1.21	1.25	1.3	1.34

DPHARMA Fundamental Trend

FCON: | Sharpe Ratio: | LTS:

DPHARMA Quarter Reports

Customize

Ann. Date	Qtr. Date	Q	FYE	Revenue [M]	PBT [M]	NP [M]	NPM	DPS	EPS	R. QoQ	R. YoY	E. QoQ	E. YoY
19 Feb 25	Q4 Dec 24	4	31 Dec 24	193.67	17.44	15.08	7.8%	2.00	1.57	7.2%	15.6%	3.3%	77.4%
08 Nov 24	Q3 Sep 24	3	31 Dec 24	208.73	20.52	15.60	7.5%	0.00	1.62	4.4%	23.3%	6.6%	73.9%
15 Aug 24	Q2 Jun 24	2	31 Dec 24	218.32	21.96	16.69	7.6%	1.00	1.73	13.1%	30.3%	9.2%	33.1%
23 May 24	Q1 Mar 24	1	31 Dec 24	192.97	20.10	15.28	7.9%	0.00	1.59	15.2%	3.7%	79.7%	32.5%
22 Feb 24	Q4 Dec 23	4	31 Dec 23	167.50	7.03	8.50	5.1%	1.80	0.88	1.0%	10.2%	5.2%	50.5%
08 Nov 23	Q3 Sep 23	3	31 Dec 23	169.24	11.43	8.97	5.3%	0.00	0.93	1.0%	4.4%	28.5%	45.1%
24 Aug 23	Q2 Jun 23	2	31 Dec 23	167.52	16.52	12.54	7.5%	0.50	1.31	16.4%	7.8%	44.6%	23.1%
22 May 23	Q1 Mar 23	1	31 Dec 23	200.47	28.29	22.63	11.3%	0.00	2.38	31.9%	7.8%	31.9%	11.5%
23 Feb 23	Q4 Dec 22	4	31 Dec 22	151.96	15.35	17.16	11.3%	1.80	1.80	14.2%	4.5%	5.0%	9.2%

DPHARMA Historical Dividends

DPHARMA Financial Ratios

EPS	6.51 sen
Trailing PE (Sector Median: 16.1)	19.5
PEG	0.26
Altman Z	1.5
Beaver	0.001
Current Ratio	4.63
Debt-Equity (DE) Ratio	0.93
FCF Yield	-0.32 %

Revenue QoQ	-7.22 %
Revenue YoY	15.62%
Profit QoQ	-3.28 %
Profit YoY	77.41 %
Profit Margin (Sector Median: 6.7)	7.7 %
ROE (ROIC: 3.91)	6.64 %
Dividend Per Share (DPS)	3.0 sen
Dividend Yield (DY)	2.36 %

DPHARMA Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 16.1)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 6.7)
ROE (ROIC: 4.11)
Altman Z

DPHARMA Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF)^{5% Growth}
Discounted Cash Flow (DCF)^{10% Growth}
Relative Valuation

Graham Formula
Graham Number
Net Tangible Asset (NTA)	0.74
Consistent QR FV

The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator Growth/Risk FV Calculator Contract Value Calculator Profit-Based Calculator Revenue-Based Calculator

Forward PE FV Calculator
Latest Profit (adjusted) [M]	15.08
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value

Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value

Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value

Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value

Market Pricing
Expected Profit (M)	461.63
Expected Revenue (M)	4254.63
Expected Growth (%)	31.0

The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

DPHARMA Directors Share Purchases (Beta)

No transaction in the last 2 months.

DPHARMA Summary

Market Cap: 1221 M.

Market Cap Class: Middlers

Number of Shares: 961 M.

Adjusted Float: 47.0%.

Stock highly correlated with

LHI (49%)

TAKAFUL (49%)

ORIENT (48%)

SCIENTX (48%)

Duopharma Biotech Berhad, formerly known as CCM Duopharma Biotech Berhad. Duopharma core competencies in the pharmaceutical industry include manufacturing, research and development, and commercialization and marketing of over 300 generic drugs, including Omesec and Prelica, as well as Consumer Healthcare (CHC) products such as CHAMPS, FLAVETTES, PROVITON, and Uphamol, which are well-known and accepted by consumers in Malaysia, the region, and around the world. With technological and commercialization agreements with trustworthy and powerful international partners, the Company has also ventured into the biosimilars space.Their headquarters is located in Kuala Lumpur, Malaysia.

Sectors: Consumer Products, Healthcare, Pharmaceuticals, Vaccine

Code: 7148

Website: http://duopharmabiotech.com/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

DPHARMA Top Shareholdings

Updated on 31-Mar-2023

Shareholder	%	Value (M)
Permodalan Nasional Berhad	44.0%	537.58
Employees Provident Fund Board	10.44%	127.59
Amanah Saham Bumiputera	4.43%	54.07
Amanah Saham Malaysia	2.31%	28.22
Tabung Haji	1.92%	23.46
Billion Victory Sdn Bhd	1.58%	19.33
National Trust Fund	1.33%	16.26
Public Islamic Treasures Growth Fund	1.06%	12.94
Manulife Investment Shariah Progress Fund	0.91%	11.12
Prulink Equity Fund	0.74%	9.05
Eastspring Investments Small-Cap Fund	0.56%	6.82
Participating Fund	0.55%	6.73
Prulink Strategic Fund	0.49%	6.01
Manulife Investment Progress Fund	0.38%	4.64
Manulife Investment Al Fauzan	0.37%	4.52
Principal Dali Equity Growth Fund	0.34%	4.13
Asean Growth Fund	0.33%	3.97
Syarikat Takaful Malaysia Keluarga Berhad	0.32%	3.96
Affin Hwang Wholesale Equity Fund	0.28%	3.41
Hong Leong Assurance Berhad	0.27%	3.34
Ooi Keng Tan	0.27%	3.31
Kenanga Shariah Growth Opportunities Fund	0.25%	3.08
Gibraltar BSN Aggressive Fund	0.19%	2.3
Hong Leong Msig Takaful Berhad	0.18%	2.26

Net Cost Calculator Lot Calculator

This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.

DPHARMA | DUOPHARMA BIOTECH BHD

1.27 (4.96%)

DPHARMA Support & Resistance

ATR Trailing Stop: 1.19

Gann Support: 1.21/1.16 | Resistance: 1.33/1.39

*Highlighted column shows significant volume at the support or resistance area.

DPHARMA Technical Trend

DPHARMA Trading Signals

Based on iSaham Screeners

DPHARMA Pivot Point

DPHARMA Fundamental Trend

FCON: | Sharpe Ratio: | LTS:

Chart:

DPHARMA Quarter Reports

DPHARMA Historical Dividends

DPHARMA Financial Ratios

DPHARMA Adjusted Financial Ratios

DPHARMA Fair Value

Weighted Average Fair Value:

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

DPHARMA Directors Share Purchases (Beta)

DPHARMA Summary

Warrant Info:

DPHARMA Top Shareholdings

Features

Services

Others

Company

DPHARMA | DUOPHARMA BIOTECH BHD

1.27 (4.96%)

DPHARMA Support & Resistance

ATR Trailing Stop: 1.19

Gann Support: 1.21/1.16 | Resistance: 1.33/1.39

*Highlighted column shows significant volume at the support or resistance area.

DPHARMA Technical Trend

DPHARMA Trading Signals

Based on iSaham Screeners

DPHARMA Pivot Point Click to learn about Pivot Point

DPHARMA Fundamental Trend

FCON: This feature is limited for iSaham Pro only | Sharpe Ratio: This feature is limited for iSaham Pro only | LTS: This feature is limited for iSaham Pro only

Chart:

DPHARMA Quarter Reports

DPHARMA Historical Dividends

DPHARMA Financial Ratios

DPHARMA Adjusted Financial Ratios

DPHARMA Fair Value

Weighted Average Fair Value: This feature is limited for iSaham Pro only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

DPHARMA Directors Share Purchases (Beta)

DPHARMA Summary

Warrant Info:

DPHARMA Top Shareholdings

DPHARMA Pivot Point

FCON: | Sharpe Ratio: | LTS:

Weighted Average Fair Value: